Dose de rappel du vaccin COVID-19 : que savons-nous à ce jour ? - 05/04/22

COVID-19 vaccine booster dose: What do we know so far?

Doi : 10.1016/j.anrea.2022.02.001

Yousra Kherabi ^1,^{^{9
Contribution équivalente au manuscrit.}}, Thibault Fiolet ^2,^{^{9
Contribution équivalente au manuscrit.}}, Sacha Rozencwajg ^3,⁴, Jean-Philippe Salaün ^4,^5,⁶, Nathan Peiffer-Smadja ^1,^7,^8,^⁎
¹ AP–HP, Bichat University Hospital, DMU INVICTUS, Infectious Diseases Department, Paris, France
² Paris-Saclay University, UVSQ, INSERM, Gustave Roussy, “Exposome and Heredity” Team, CESP UMR1018, Villejuif, France
³ AP–HP, Bichat University Hospital, DMU PARABOL, Department of Anaesthesiology and Critical Care, Paris, France
⁴ Paris University, Paris, France
⁵ Normandie Univ, UNICAEN, Inserm, GIP Cyceron, Institut Blood and Brain @Caen-Normandie (BB@C), UMR-S U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Caen, France
⁶ CHU Caen, Department of Anaesthesiology and Critical Care Medicine, Caen University Hospital, avenue de la Côte de Nacre, Caen, France
⁷ INSERM, IAME, Paris University, Paris, 75006, France
⁸ National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK

^⁎Nathan Peiffer-Smadja, Infectious Diseases Department, Bichat Claude-Bernard Hospital, Assistance-Publique, Hôpitaux de Paris, 46, rue Henri-Huchard, B.P. 416–75870, Paris Cedex 18, France.Infectious Diseases Department, Bichat Claude-Bernard Hospital, Assistance-Publique, Hôpitaux de Paris46, rue Henri-Huchard, B.P. 416–75870Paris Cedex 18France

Il testo completo di questo articolo è disponibile in PDF.